EGFR and non-small cell lung carcinoma: As shown in Fig. 3D, combined inhibition of PI4KIIα and EGFR was more effective in inhibiting cell viability compared to single application of either method in the three cell lines as indicated, in particular in NSCLC A549 cells and the triple-negative breast cancer cell line MDA-MB231 cells.